A hapten (DNP) model of topically induced ocular anaphylaxis has been developed. Rats immunized with DNP-Ascaris were skin-tested with DNP-bovine serum albumin (DNP-BSA) and Evans blue and challenged topically with varying amounts of di-DNP-lysine. The degree of clinical conjunctival edema was assessed, and eye tissues were evaluated histologically. Clinical conjunctival edema and histologic mast cell degranulation increased with higher concentration of di-DNP-lysine. In general, rats with positive skin tests showed more clinical conjunctival edema and more mast cell degranulation than those with negative skin tests. Three other groups of rats with positive skin tests to the DNP-BSA were injected intravenously with 125I-BSA and challenged topically with di-DNP-lysine. Retention of 125I-BSA in ocular adnexa and in globes was higher in di-DNP-lysine- than in PBS-challenged eyes. The hapten model simulates the ocular component of human hay fever in that ocular anaphylaxis is induced in immunized rats by topical challenge with antigen alone.

Download full-text PDF

Source

Publication Analysis

Top Keywords

ocular anaphylaxis
12
clinical conjunctival
12
conjunctival edema
12
skin tests
12
hapten model
8
challenged topically
8
mast cell
8
cell degranulation
8
rats positive
8
positive skin
8

Similar Publications

Registries in allergy: Structure, target groups, and key findings of allergy-focused registries in Germany.

Allergol Select

December 2024

Division of Allergy and Immunology, Department of Dermatology, Venerology and Allergology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

In allergology, clinical registries fill knowledge gaps of epidemiology, mechanisms of allergic diseases, and real-world treatment outcomes. Considering the continuous rise of allergic diseases worldwide, registries become increasingly important for the optimization and harmonization of patient care. In the current review, we present four ongoing allergy-focused registries initiated in Germany.

View Article and Find Full Text PDF

[Clinical case of anaphylaxis due to eye drops].

Rev Alerg Mex

February 2024

Sociedad Ecuatoriana de Alergia, Asma e Inmunología capítulo Centro Sur-Occidental (SEAAISO).

Background: Anaphylaxis is a severe systemic allergic reaction that can be life-threatening, timely diagnosis and treatment is required in these patients, one of the most frequent triggers is pharmacological.

Objective: To report the case of a patient who presented anaphylaxis due to eye drops.

Case Report: A 7-year-old male with a history of rhinitis and asthma with good control.

View Article and Find Full Text PDF

Background: In allergic rhinitis and asthma, adolescents and young adult patients are likely to differ from older patients. We compared adolescents, young adults and adults on symptoms, control levels, and medication adherence.

Methods: In a cross-sectional study (2015-2022), we assessed European users of the MASK-air mHealth app of three age groups: adolescents (13-18 years), young adults (18-26 years), and adults (>26 years).

View Article and Find Full Text PDF

A Case Report of Venezuelan Suntiger Tarantula (Psalmopoeus Irminia) Envenomation and Review of Tarantula Exposures.

J Emerg Med

September 2023

Rocky Mountain Poison and Drug Safety, Denver Health and Hospital Authority, Denver, Colorado; Department of Emergency Medicine, University of Colorado Hospital, Aurora, Colorado.

Background: Tarantula envenomations are encountered infrequently but may increase with increased exotic animal ownership. This case report presents the first documented toxicity from a Venezuelan suntiger tarantula (VST), Psalmopoeus irminia, and provides a general framework for approaching patients with tarantula exposures.

Case Report: A 35-year-old man presented to an emergency department 4 h after experiencing a bite from his pet VST.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!